Transgenomic, Inc. and SubsidiarySummary Financial ResultsUnaudited Condensed Consolidated Balance Sheets(dollars in thousands) | |||
(Unaudited)June 30,2010 | December 31,2009 | ||
ASSETS | |||
| CURRENT ASSETS: | |||
Cash and cash equivalents | $ 5,416 | $ 5,642 | |
Accounts receivable (net of allowances for bad debts of $295 and $310, respectively) | 3,827 | 4,522 | |
Inventories (net of allowance for obsolescence of $536 and $507, respectively) | 3,321 | 3,552 | |
Prepaid expenses and other current assets | 577 | 738 | |
Total current assets | 13,141 | 14,454 | |
| PROPERTY AND EQUIPMENT, NET | 843 | 967 | |
| OTHER ASSETS: | |||
Other assets (net of accumulated amortization of $537 and $525, respectively) | 462 | 583 | |
$14,446 | $16,004 | ||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||
| CURRENT LIABILITIES: | |||
Accounts payable | $ 889 | $ 1,013 | |
Other accrued expenses | 2,607 | 2,517 | |
Accrued compensation | 793 | 573 | |
Total current liabilities | 4,289 | 4,103 | |
Other long term liabilities | 182 | 239 | |
Total liabilities | 4,471 | 4,342 | |
| STOCKHOLDERS' EQUITY | 9,975 | 11,662 | |
$ 14,446 | $ 16,004 | ||
